Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 2 (2005), Issue 1 (January)

1. Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease.
   Am J Med, 117(12): 925-31. [Abstract] [Full-text]
2. Cerebrovascular hemodynamics in chronic hypertensive pregnant women who later develop superimposed preeclampsia.
   J Soc Gynecol Investig, 12(1): 28-32. [Abstract] [Full-text]
3. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension.
   Circulation, 111(1): 63-9. [Abstract] [Full-text]
4. Psychological stress tasks in the prediction of blood pressure level and need for antihypertensive medication: 9-12 years of follow-up.
   Health Psychol, 24(1): 77-87. [Abstract] [Full-text]
5. Extracts enriched in different polyphenolic families normalize increased cardiac NADPH oxidase expression while having differential effects on insulin resistance, hypertension, and cardiac hypertrophy in high-fructose-fed rats.
   J Agric Food Chem, 53(1): 151-7. [Abstract] [Full-text]
6. Vasopressin-stimulated CFTR Cl- currents are increased in the renal collecting duct cells of a mouse model of Liddle's syndrome.
   J Physiol, 562: 271-84. [Abstract] [Full-text]
7. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies.
   Am J Hum Genet, 76(2): 268-75. [Abstract] [Full-text]
8. Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension.
   Am J Physiol Renal Physiol, 288(2): F245-52. [Abstract] [Full-text]
9. Genetic AT1A receptor deficiency attenuates cold-induced hypertension.
   Am J Physiol Regul Integr Comp Physiol, 288(2): R433-9. [Abstract] [Full-text]
10. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression.
    Am J Physiol Endocrinol Metab, 288(2): E353-9. [Abstract] [Full-text]
11. Cardiac remodeling after long-term stimulation by antibodies against the alpha1-adrenergic receptor in rats.
    Clin Immunol, 114(2): 164-73. [Abstract] [Full-text]
12. Cardiovascular risk factors in youth with implications for aging: the Bogalusa Heart Study.
    Neurobiol Aging, 26(3): 303-7. [Abstract] [Full-text]
13. The role of unilateral nephrectomy in the treatment of nephrogenic hypertension in children.
    BJU Int, 95(1): 140-2. [Abstract] [Full-text]
14. Linkage analysis of chromosome 1 with essential hypertension and blood pressure quantitative traits in Chinese families.
    Ann Hum Genet, 69: 45-54. [Abstract] [Full-text]
15. beta2-Adrenergic receptor gene variations associated with stage-2 hypertension in northern Han Chinese.
    Ann Hum Genet, 69: 36-44. [Abstract] [Full-text]
16. Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension.
    Eur J Clin Invest, 35(1): 8-12. [Abstract] [Full-text]
17. Genotyping the -6A/G functional polymorphism in the core promoter region of angiotensinogen gene by microchip electrophoresis.
    Electrophoresis, 26(1): 219-24. [Abstract] [Full-text]
18. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients.
    Eur J Heart Fail, 7(1): 75-9. [Abstract] [Full-text]
19. Assessment of left atrial input impedance in normal subjects and in hypertensive patients.
    Eur J Heart Fail, 7(1): 63-8. [Abstract] [Full-text]
20. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
    Diabetes Obes Metab, 7(1): 47-55. [Abstract] [Full-text]
21. Hemorrhagic pheochromocytoma associated with systemic corticosteroid therapy and presenting as myocardial infarction with severe hypertension.
    J Clin Endocrinol Metab, 90(1): 563-9. [Abstract] [Full-text]
22. Liddle's syndrome caused by a novel mutation in the proline-rich PY motif of the epithelial sodium channel beta-subunit.
    J Clin Endocrinol Metab, 90(1): 340-4. [Abstract] [Full-text]
23. Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats.
    Can J Physiol Pharmacol, 82(11): 976-85. [Abstract] [Full-text]
24. Differential cardiovascular responses to stressors in hypertensive and normotensive rats.
    Exp Physiol, 90(1): 141-50. [Abstract] [Full-text]
25. Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients.
    Pharmacogenomics J, 5(1): 14-20. [Abstract] [Full-text]
26. Control of oxidative stress in microcirculation of spontaneously hypertensive rats.
    Am J Physiol Heart Circ Physiol, 288(2): H805-12. [Abstract] [Full-text]
27. Effects of continuous negative extra-abdominal pressure on cardiorespiratory function during abdominal hypertension: an experimental study.
    Intensive Care Med, 31(1): 105-11. [Abstract] [Full-text]
28. Hypertension attenuates cell-to-cell communication in hamster retractor muscle feed arteries.
    Am J Physiol Heart Circ Physiol, 288(2): H861-70. [Abstract] [Full-text]
29. Salt-induced ANG II suppression impairs the response of cerebral artery smooth muscle cells to prostacyclin.
    Am J Physiol Heart Circ Physiol, 288(2): H908-13. [Abstract] [Full-text]
30. Physical exercise decreases neuronal activity in the posterior hypothalamic area of spontaneously hypertensive rats.
    J Appl Physiol, 98(2): 572-8. [Abstract] [Full-text]
31. Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats.
    Am J Physiol Heart Circ Physiol, 288(2): H729-36. [Abstract] [Full-text]
32. Daily exercise-induced cardioprotection is associated with changes in calcium regulatory proteins in hypertensive rats.
    Am J Physiol Heart Circ Physiol, 288(2): H532-40. [Abstract] [Full-text]
33. Contribution of the subfornical organ to angiotensin II-induced hypertension.
    Am J Physiol Heart Circ Physiol, 288(2): H680-5. [Abstract] [Full-text]
34. Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats.
    Am J Physiol Heart Circ Physiol, 288(2): H517-24. [Abstract] [Full-text]
35. The alpha2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro.
    Am J Physiol Heart Circ Physiol, 288(2): H477-85. [Abstract] [Full-text]
36. Interventions used to improve control of blood pressure in patients with hypertension.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
37. Differences in overshoot of blood pressure after head-up tilt in two groups with chronic autonomic failure: pure autonomic failure and multiple system atrophy.
    J Neurol, 252(1): 72-7. [Abstract] [Full-text]
38. Lack of effect of captopril on the metabolism of an artificial lipid emulsion similar to chylomicrons in hypertensive hypercholesterolemic patients.
    Arq Bras Cardiol, 83(6): 512-5; 508-11. [Abstract] [Full-text]
39. Global burden of hypertension: analysis of worldwide data.
    Lancet, 365(9455): 217-23. [Abstract] [Full-text]
40. Having a regular physician and attempted weight loss after screening for hypertension or hypercholesterolemia.
    Int J Obes (Lond), 29(2): 223-7. [Abstract] [Full-text]
41. Linkage and linkage disequilibrium analysis of the lipoprotein lipase gene with lipid profiles in Chinese hypertensive families.
    Clin Sci (Lond), 108(2): 137-42. [Abstract] [Full-text]
42. Folate intake and the risk of incident hypertension among US women.
    JAMA, 293(3): 320-9. [Abstract] [Full-text]
43. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin.
    Proc Natl Acad Sci U S A, 102(3): 785-90. [Abstract] [Full-text]
44. The coming epidemic: hypertension in rural Kyrgyzstan, Central Asia.
    J Hum Hypertens, 19(2): 145-8. [Abstract] [Full-text]
45. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population?
    J Hum Hypertens, 19(2): 165-72. [Abstract] [Full-text]
46. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    J Hum Hypertens, 19(2): 139-44. [Abstract] [Full-text]
47. Treatment of systolic hypertension: spotlight on recent studies with angiotensin II antagonists.
    J Hum Hypertens, 19(2): 93-102. [Abstract] [Full-text]
48. Familial aggregation and coaggregation of history of hypertension and stroke.
    J Hum Hypertens, 19(2): 119-25. [Abstract] [Full-text]
49. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    J Hum Hypertens, 19(2): 111-7. [Abstract] [Full-text]
50. Long-term effects of statins on arterial pressure and stiffness of hypertensives.
    J Hum Hypertens, 19(2): 103-9. [Abstract] [Full-text]
51. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension.
    J Hum Hypertens, 19(2): 149-54. [Abstract] [Full-text]
52. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
    J Hum Hypertens, 19(2): 133-8. [Abstract] [Full-text]
53. Alteration of binding sites for [3H]P1075 and [3H]glibenclamide in renovascular hypertensive rat aorta.
    Acta Pharmacol Sin, 26(1): 69-76. [Abstract] [Full-text]
54. T102C genetic polymorphism of the 5-HT2A receptor in Chinese hypertensive patients and healthy controls.
    Clin Exp Pharmacol Physiol, 31(12): 847-9. [Abstract] [Full-text]
55. G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
    Annu Rev Med, 56: 17-28. [Abstract] [Full-text]
56. Autonomic nervous system activity in normotensive subjects with a family history of hypertension.
    Clin Auton Res, 14(6): 369-75. [Abstract] [Full-text]
57. Down-regulation of calpain 9 is linked to hypertensive heart and kidney disease.
    Cell Physiol Biochem, 15(1): 109-16. [Abstract] [Full-text]
58. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage.
    J Intensive Care Med, 20(1): 34-42. [Abstract] [Full-text]
59. Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats.
    Cardiovasc Res, 65(3): 743-50. [Abstract] [Full-text]
60. Testing for statistical discrimination in health care.
    Health Serv Res, 40(1): 227-52. [Abstract] [Full-text]
61. Midlife cardiovascular risk factors and risk of dementia in late life.
    Neurology, 64(2): 277-81. [Abstract] [Full-text]
62. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe.
    Neurology, 64(2): 263-7. [Abstract] [Full-text]
63. Daily life activity and the risk of developing hypertension in middle-aged Japanese men.
    Arch Intern Med, 165(2): 214-20. [Abstract] [Full-text]
64. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study.
    Arch Intern Med, 165(2): 207-13. [Abstract] [Full-text]
65. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Arch Intern Med, 165(2): 161-8. [Abstract] [Full-text]
66. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials.
    Arch Intern Med, 165(2): 150-6. [Abstract] [Full-text]
67. Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus.
    Thromb Res, 115(4): 277-85. [Abstract] [Full-text]
68. Prognostic impact of low-shear whole blood viscosity in hypertensive men.
    Eur J Clin Invest, 35(2): 93-8. [Abstract] [Full-text]
69. Losartan increases bradykinin levels in hypertensive humans.
    Circulation, 111(3): 315-20. [Abstract] [Full-text]
70. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis.
    Circulation, 111(3): 328-33. [Abstract] [Full-text]
71. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.
    J Am Soc Nephrol, 16(2): 529-38. [Abstract] [Full-text]
72. Different effect of losartan and amlodipine on penile structures in male spontaneously hypertensive rats.
    Am J Nephrol, 24(6): 614-23. [Abstract] [Full-text]
73. Hypertension and the vanishing kidney.
    Pediatr Nephrol, 20(2): 229-31. [Abstract] [Full-text]
74. Long-term adaptation of renal ion transporters to chronic diuretic treatment.
    Am J Nephrol, 24(6): 595-605. [Abstract] [Full-text]
75. Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats.
    Am J Nephrol, 24(6): 587-94. [Abstract] [Full-text]
76. Fetal hypertension and abnormal Doppler velocimetry in an ovine model of intrauterine growth restriction.
    Am J Obstet Gynecol, 192(1): 272-9. [Abstract] [Full-text]
77. Predictors of ischemic versus hemorrhagic strokes in hypertensive patients.
    J Coll Physicians Surg Pak, 15(1): 22-5. [Abstract] [Full-text]
78. Evidence-based care for the elderly with isolated systolic hypertension.
    Nurs Health Sci, 7(1): 67-75. [Abstract] [Full-text]
79. Prevention and treatment of postpartum hypertension.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
80. Association between iris constitution and apolipoprotein e gene polymorphism in hypertensives.
    J Altern Complement Med, 10(6): 1101-5. [Abstract] [Full-text]
81. The use of nicardipine for electroconvulsive therapy: a dose-ranging study.
    Anesth Analg, 100(2): 378-81. [Abstract] [Full-text]
82. Hypertension and hypertensive heart disease are associated with increased ostial pulmonary vein diameter.
    J Cardiovasc Electrophysiol, 16(1): 2-5. [Abstract] [Full-text]
83. The effect of hypertension on the risk for kidney cancer in Korean men.
    Kidney Int, 67(2): 647-52. [Abstract] [Full-text]
84. Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides.
    Kidney Int, 67(2): 631-7. [Abstract] [Full-text]
85. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.
    Nephrol Dial Transplant, 20(2): 349-53. [Abstract] [Full-text]
86. Admixture mapping for hypertension loci with genome-scan markers.
    Nat Genet, 37(2): 177-81. [Abstract] [Full-text]
87. Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study.
    BMJ, 330(7485): 230. [Abstract] [Full-text]
88. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects.
    Hypertension, 45(2): 216-21. [Abstract] [Full-text]
89. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
    Hypertension, 45(2): 198-202. [Abstract] [Full-text]
90. Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension.
    Hypertension, 45(2): 193-7. [Abstract] [Full-text]
91. NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1.
    Hypertension, 45(2): 283-7. [Abstract] [Full-text]
92. Association between the CYP3A5 genotype and blood pressure.
    Hypertension, 45(2): 294-8. [Abstract] [Full-text]
93. Microangiopathic hemolysis and renal failure in malignant hypertension.
    Hypertension, 45(2): 246-51. [Abstract] [Full-text]
94. Short- and long-term incidence of stroke in white-coat hypertension.
    Hypertension, 45(2): 203-8. [Abstract] [Full-text]
95. Noninvasive evaluation of the coronary arteries with multislice computed tomography in hypertensive patients.
    Hypertension, 45(2): 227-32. [Abstract] [Full-text]
96. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
    Clin Chem, 51(2): 386-94. [Abstract] [Full-text]
97. Expression of mineralocorticoid receptors mRNA in the brain, heart and kidney of Sprague Dawley rats with renovascular hypertension.
    Brain Res Bull, 65(1): 23-9. [Abstract] [Full-text]
98. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk.
    Lancet, 365(9457): 434-41. [Abstract] [Full-text]
99. Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats.
    Eur J Pharmacol, 508(1): 205-10. [Abstract] [Full-text]
100. Differential effect of experimental hypertension and hypercholesterolemia on adventitial remodeling.
     Arterioscler Thromb Vasc Biol, 25(2): 447-53. [Abstract] [Full-text]

© 2004-2010 Hypertension Research Today. All Rights Reserved.